Welcome to UK420

Register now to gain access to all of our features. Once registered and logged in, you will be able to contribute to this site by submitting your own content or replying to existing content. You'll be able to customize your profile, receive reputation points as a reward for submitting content, while also communicating with other members via your own private inbox, plus much more!

This message will be removed once you have signed in.

Search the Community: Showing results for tags 'world'.

More search options

  • Search By Tags

    Type tags separated by commas.
  • Search By Author

Content Type


  • Welcome to UK420
    • New Members
    • Announcements
  • Cultivation
    • Strain Base
    • Breeders Help Desks
    • Compost and Pots
    • Hydroponics
    • Outdoor Growing
    • Propagation, Cloning and Mother Plants
    • Auto Flowering
    • Growroom Design
    • Problem Solver
    • Harvesting and Processing
    • Grow Diaries
    • Cream Of The Crop
  • Cannabis Culture
    • News, Views and Politics
    • Medicinal Cannabis
    • Smokers Lounge
    • Uk420 Competitions
  • Sponsor Support
    • Grow and Harvest
    • Intense Nutrients
    • Vapefiend - The Vaporizer Specialists
    • DIY LED UK
  • Community Lifestyle
    • Green Living
    • Gardening
    • Growers Wives Club
    • Creative Arts
    • Food & Drink
    • Travel
    • Sport


  • Community Calendar

Found 82 results

  1. hi Pepsi shoots down rumors that it is considering cannabis following a report that Coca-Cola is eyeing CBD-infused beverages PepsiCo has no plans to enter into the cannabis business, the company said in a call with investors on Tuesday. Insiders have been buzzing about Pepsi's potential interest in CBD-infused beverages or snacks, following a report that Coca-Cola is eyeing a deal with marijuana producer Aurora Cannabis. CBD is already a $1 billion business, and analysts say that CBD-infused beverages could become a huge new category, similar to energy drinks. Insiders have been buzzing about PepsiCo considering a move into the cannabis business, following a report that Coca-Cola is eyeing a deal with marijuana producer Aurora Cannabis. However, on Tuesday, the snack-and-beverage giant shot down the rumors during a call with investors. Hugh Johnson, PepsiCo's CFO, said in response to a question on cannabis-infused products that the company looks at everything, but has no plans at this point to enter into the market, due in part to regulatory issues. In late September, analysts said that they saw Coca-Cola's reported interest in CBD as not too surprising, as CBD-infused drinks could be a boon for the beverage giant. CBD is already a booming, $1 billion business, and it is being used as an ingredient in salves, oils, balms, and beverages, despite continuing legal questions. Beverage giants investing in CBD-infused drinks could result in the creation of a new mainstream category of beverage. A deal between Coca-Cola and Aurora Cannabis could "broaden the reach of cannabis-­infused beverages into functional wellness categories, enabling KO to potentially one day 'own' the non­recreational cannabis-­infused beverage category," Wells Fargo analyst Bonnie Herzog wrote in a note to investors. With the potential of a new category looming, news of PepsiCo's interest in the industry seemed likely to follow. Vivien Azer, an analyst at Cowen, said in a note to clients in late September that she "would not be surprised" to hear of a deal between PepsiCo and a cannabis company, proposing that a CBD brand could serve as a "good complement" to PepsiCo's Gatorade franchise. However, it seems PepsiCo isn't ready to officially signal interest in CBD or cannabis — at least, not yet. Cannabis stocks have been booming, to a degree that has raised concerns among certain investors. Regulation remains murky, and CBD's actual impact is still unknown. "The question is: Is it going to be something akin to energy drinks — a new category that is trendy at first, that actually grows into a meaningful long-term business? Or is it going to be sort of a fad?" Duane Stanford, the executive editor of industry publication Beverage Digest, told Business Insider. http://uk.businessinsider.com/pepsi-shoots-down-cannabis-deal-rumors-2018-10 Bongme
  2. Hi Kids pick up marijuana at younger age if their mothers use the drug, Harvard study finds Daily Mail When mom uses marijuana, kids are more likely to try the drug at a younger age, a new study shows. When mothers used cannabis during the first 12 years of a child's life, there was a 40 percent higher likelihood the kid would start using the drug earlier than peers whose moms weren't using, researchers reported in the American Journal of Preventive Medicine. On average, children whose mothers used marijuana tried it themselves an average of two years earlier than peers whose mothers didn't use the drug. That puts those kids at risk for a host of marijuana-linked problems, said lead study author Natasha Sokol, who was a doctoral student at the Harvard T.H. Chan School of Public Health when the research was done. Kids with mothers who used marijuana were at increased risk of starting to use the drug themselves before age 17. Their peers were more likely to start at 18. The time between 16 and 18 'is a critical period of development,' said Sokol, who is now at the Center for Alcohol and Addiction Studies at the Brown University School of Public Health. 'Marijuana might be disrupting certain aspects of brain development, including the development of the endocannabinoid system. It's been associated with depression and, in predisposed individuals, there seems to be an increased risk of the development of psychosis.' Marijuana use at this age can also affect a child's ability learn, Sokol said. 'Missing school or functioning at a lower level in school is a big deal,' she said. 'Especially if it's for an extended period of time.' Sokol and colleagues analyzed data from participants in the National Longitudinal Survey of Youth and their biological children who signed on for the NLSY Child and Young Adults survey. The NLSY is a nationally representative survey that included 12,686 individuals living in the U.S. in 1979 between the ages of 14 and 21. NLSY participants were interviewed annually up until 1994 and then biennially after that. Out of 4,440 mother-child pairs identified by the researchers, 2,983 children, or 67 percent, and 1,053 moms, or 35 percent, said they used marijuana. One limitation of the study, Sokol said, is the researchers didn't have information on whether the kids knew their moms were using cannabis. While that is a limitation of the study, 'we also know that children are much more aware than we think they are,' said Dr. Michael Lynch, a toxicologist and emergency medicine physician and medical director of the Pittsburgh Poison Center at the University of Pittsburgh Medical Center. 'That's been proven again and again.' Lynch said he wasn't surprised to see children imitating behaviors modeled by their parents. But, 'it's nice to have a peer-reviewed work that identifies the risk that children are more likely to start using marijuana if they grow up in homes with a mother who uses the drug,' he added. The findings are 'concerning' Lynch said. 'That's because it's in the context of expanding use and a more permissive culture around marijuana use,' he added. 'All - even proponents - agree that younger initiation is unhealthy. That's been fairly well studied, from an academic and career standpoint and from a cognitive development standpoint.' Moreover, Lynch said, people who start marijuana at a younger age are at greater risk of addiction to either marijuana or prescription opioids. 'The finding is important but not surprising,' said Dr. Salomeh Keyhani, a professor of medicine at the University of California, San Francisco. 'Studies of maternal tobacco smoking and adolescent initiation have had similar findings.' 'The results are particularly concerning given the unresolved debate on the association of adolescent use of cannabis and decreases in IQ,' Keyhani said. 'The results are also concerning because there is no coordinated public health campaign that is informing the public of the potential risks of cannabis use.' Sokol hopes her new findings won't be misused. 'I don't think this study needs to be evidence against legalization,' she said. 'That's not a successful public health policy.' https://www.dailymail.co.uk/health/article-6203545/Kids-pick-marijuana-younger-age-mothers-use-drug-study-finds.html 57 comments Top Hitter mama_mia, St. James, Barbados If marijuana was the only drug I had to worry about with my two teenagers, I would be happy. Bongme
  3. Hi Tea Break news Does Coca-Cola think it's high time for cannabis coke? Company 'close' to joint venture to sell drinks infused with marijuana Daily Mail Coca-Cola is said to be close to a deal that could see it infuse cans of soft drink with cannabis. The US giant is said to be in 'serious' discussions with a cannabis producer as it looks to grab a slice of the burgeoning marijuana market. A deal with the firm, Aurora Cannabis, could lead to Coca-Cola selling drinks infused with marijuana, which is said to have health benefits such as easing inflammation, pain and cramping. The conglomerate is likely to use cannabidiol, known as CBD, to develop the drinks. CBD is the non-psychoactive ingredient found in cannabis that is said to help ease pain but without the buzz or high some users seek. According to US-based Bloomberg news, sources close to negotiations said Coca-Cola and Aurora are 'pretty advanced down the path' of doing a deal. 'It's going to be more of a recovery drink,' the source added. If Coca-Cola seals a contract with Aurora it would be the first major soft drinks firm to make a move into the marijuana market. Canada is set to legalise the recreational use of cannabis next month as more states across the US make it legal. CBD oil is already on the shelves in the UK and is increasingly popular among those seeking an alternative to aid sleep and alleviate mental health conditions such as depression and anxiety. However, it can only be sold as a food supplement. In 2016, the Medicines and Healthcare products Regulatory Agency said items containing CBD would have to be licensed if they were advertised for medical purposes. A spokesman for Coca-Cola refused to comment on speculation but added: 'Along with many others in the beverage industry, we are closely watching the growth of non-psychoactive CBD as an ingredient in functional wellness beverages around the world. 'The space is evolving quickly. No decisions have been made at this time.' A spokesman for Aurora, which is based in Canada, said: 'Aurora has expressed specific interest in the infused beverage space, and we intend to enter that market.' There are growing calls for a separate type of oil derived from cannabis that contains THC, the psychoactive ingredient of the plant, to be more widely available. Home Secretary Sajid Javid announced in June that doctors in the UK would be able to legally prescribe cannabis-derived medicinal products under strict conditions. It followed the cases of Alfie Dingley, six, of Kenilworth, Warwickshire, and Billy Caldwell, 12, from County Tyrone, Northern Ireland, who were given temporary licences for the oil to treat their severe epileptic seizures. The boys were originally denied the oil after it was confiscated at border control. Mr Javid stressed it was not a move towards the legalisation of cannabis, which is currently a controlled drug. https://www.dailymail.co.uk/news/article-6176903/Coca-Cola-talks-produce-marijuana-infused-drinks.html 518 Comments Top Hitter JeremyOsborne, Richmond Upon Thames London , United Kingdom We love you Coca-Cola Bongme
  4. hi Vaping Weed Safer than Smoking Cigs Vaping cannabis seems to have even fewer health risks than smoking it As rational, health-conscious men, we should avoid behaviors that likely will cause harm even under the best of circumstances. Certain sports and physical activities may cause harm, but with proper training and equipment, these risks can be minimized if not completely eliminated. Smoking, on the other hand, is detrimental to our health. At least, smoking tobacco is. What about smoking other things, or vaping instead? Even tobacco company Reynolds American Inc. admits that These diseases and others can show up after years without smoking. My father died of chronic obstructive pulmonary disease, though he stopped smoking decades before. For smokers worried about their health, Reynolds adds, “The best course of action … is to quit.” Anything that can decrease or eliminate smoking sounds like a positive development. Vaping may be just the ticket. Though cannabis—marijuana if you prefer—can be smoked like tobacco (or mixed with tobacco), that’s not the only way to experience it. Vaporizers—such as a vape pen—heat but don’t burn the weed, producing an aerosol (vapor) with fewer carcinogens and lung irritants. They, however, are too new to conclude that they are entirely risk-free. Not that all noncombustible products are created equal. There are important differences between devices, the materials from which they are made and the forms of products put into them. A so-called e-liquid containing nicotine is most common. A Johns Hopkins study detected the presence of potentially dangerous elements, including lead and arsenic, in e-cigarette liquids, with much higher quantities in vaping pens with fresh metal heating coils. Some have ceramic heating coils, others quartz, both of which seem to release less or no lead and arsenic. Cancer and other diseases aren’t the only problems with nicotine. It also is addictive. Cancer Research UK states that “Nicotine causes addiction in much the same way as heroin or cocaine and it is just as addictive as these ‘harder’ drugs.” Marijuana, according to the best science, has less risk of addiction, maybe mostly psychologically. E-cigarettes and vaping pens can function as nicotine replacement therapy (NRT), reducing the risk of smoking-related diseases, just as methadone or buprenorphine (Suboxone) can function as medication-assisted treatment (MAT) in heroin rehab programs. Whether smoking or vaping marijuana has the same or similar health risks isn’t asked very often, even by marijuana opponents. (They tend to focus on whether or not cannabis is addictive, and if so, how much.) Maybe that’s because they know they won’t like the answer. Though cannabis research is limited—in size and number, by the inability to get legal, government-grown marijuana for study—most studies conclude there is little or no risk of cancer associated with smoking marijuana, particularly when compared with tobacco. Although marijuana smoke does have many of the same carcinogens as tobacco smoke, it seems cannabis also has some cancer-retarding properties that may reduce or eliminate the risks. That doesn’t mean there may not be other, significant lung health risks short of cancer. Vaping cannabis seems to have even fewer health risks than smoking it, though again there is not enough evidence to say there is no risk. Since there’s a chance that it may cause harm, it would be more responsible, more grown up, to not smoke or vape anything. That’s the problem. Smoking is adolescent. Almost no one starts smoking as an adult. Nicotine is so incredibly addictive, however, that once you start it is very difficult to quit. To paraphrase the Jesuits and Muriel Spark, “Give me a child at an impressionable age and they are mine for life.” Likewise, marijuana may do long-term damage to the developing teen-aged brain that it doesn’t to the adult brain. The way it looks right now, vaping tobacco is less harmful than smoking it since the combustion releases more carcinogens and the smoke irritates the lungs more than the vapor. Marijuana seems (to all but the most rabid anti-grass zealots) to be less harmful than vaping tobacco, and vaping marijuana is safer still. Another argument in favor of cannabis: Although tobacco has no currently accepted or rationally argued health benefits, the same is not true of marijuana. Many US politicians and some physicians say that marijuana has no proven benefits either, but that, again, maybe because it is too difficult to get permission to test it. Meanwhile, there are many people who testify to the health benefits of cannabis for anxiety, post-traumatic stress disorder, chronic pain management and even withdrawal from deadly opioid drugs. Say what you like about marijuana, there is not a single documented case of anyone dying from an overdose of marijuana, despite many legalization and decriminalization opponents looking for one. It seems to be physically impossible. Although marijuana is illegal at the federal level, 60 percent of the US population thinks it should be legal, recreational as well as medical, and about the same percentage of states have passed ballot measures or laws making it so under their laws. The US tried Prohibition for alcohol, which was and is a health hazard, but it didn’t work. Many people decided they’d rather break the law than stop drinking. All that was accomplished was the creation of a vast criminal apparatus to feed that desire. The crackdown on marijuana, heroin, and opioid prescription painkillers has had a similar effect, leading to drug cartels, crime, overdose deaths, and violence. Not so curiously, in states where recreational marijuana has been legalized, the amount of crime, violence and overdose deaths has decreased. The same is true of areas where safe injection sites have been established, where addicts can test their drugs to make sure they’re getting what they paid for (some prescription painkillers are counterfeits, using cheaper, easier to find, but much stronger opioids such as fentanyl), clean needles and medical assistance if needed. Vaping marijuana is not a monolith either, and while there is little research about the safety or dangers of vaping, some methods may be safer than others. First, there’s the hardware, from a hand-held bong or water pipe to a vape pen. They come in different materials, too, which may or may not affect the release of carcinogens. The most common form of cannabis for vaping pens is a concentrate known as butane hash oil (BHO), typically made by pouring lighter fluid through poor-quality pot and filtering it. Other vaporizers use loose pot, whole bud or ground, with heated water. There’s even a Keurig-style cannabis device using pre-filled pods that may come to market soon. If vaping appears to be the safest way of using tobacco and marijuana, in the interests of harm reduction we should encourage users to switch. Some people may continue using longer than they otherwise would have, but fewer people will die. That seems a fair trade-off. https://goodmenproject.com/featured-content/vaping-weed-safer-than-smoking-cigs-ndgt/ Bongme
  5. hi 5 things to know about cannabis, according to UW pharmacist profs Effects of marijuana can be pleasant, unpleasant or medicinal, says pharmacy prof A team of pharmacists at the University of Waterloo released a new video telling people the five basic things they need to know about cannabis. The video is narrated by professor Michael Beazely, who gives the audience an idea of what using pot feels like and how long the effects can last. "Like with any drugs, there are pleasurable effects, in some cases, there are medicinal effects and there are adverse affects," said Beazely on CBC K-W's The Morning Edition. Beazely said the video was produced by his colleague, professor Kelly Grindrod. "This had a clear goal, it was ... to really give five basic points about cannabis for health professionals, for pharmacists, but in this case, the video works well for everyone," he said. 1. The affects of cannabis can vary. The well known components are tetrahydrocannabinol (THC) or cannabidiol (CBD). THC makes people feel high and can cause hunger, sleepiness, paranoia and anxiety. CBD doesn't get people high and is believed to be more medicinal. The amounts of THC or CBD can vary in different strains. 2. There is emerging evidence that cannabis can be used for chronic nerve pain, palliative care, nausea and vomiting from chemotherapy, spasticity from multiple sclerosis and certain drug-resistant seizure disorders in children. 3. For every hundred people who use cannabis, many will feel high, sleepy or dizzy. Ten to 20 people will have muscle twitching, low blood pressure or feel intensely happy or uneasy. Five to 10 people will experience cannabis use disorder or memory trouble and up to five people will have acute psychosis or dissociation. 4. Inhaled cannabis starts working in minutes and last around four hours. Edible products start working around in an hour or more, lasts around six hours in adults and 12 hours in kids. 5. Cannabis should be avoided in pregnancy, breastfeeding and when there is a personal or family history of psychosis. It can double the risk of psychosis in young people, especially if a sibling or parent has a psychiatric disorder. In addition, Beazely said driving and using heavy machinery should be avoided after consuming cannabis, as it can impair motor function and coordination. It should also be kept out reach of children to prevent accidental poisoning. "Whenever possible, avoid smoking cannabis. Vaping and edibles are thought to be safer," he said. https://www.cbc.ca/news/canada/kitchener-waterloo/uw-5-things-to-know-cannabis-1.4812744 Audio and Vid On Link Bongme
  6. Hi Summer Got You Feeling Stressed? Cannabis May Help A study from 2009 indicated that Cannabis was used for relaxation, stress relief and anxiety reduction, while statistics for women users were around 10% higher Relaxation is the most widely cited reason why people consume cannabis. (According to 55 percent of respondents polled in a 2009 study) Cannabis has been considered a stress reliever for nearly half a millennia and modern science has verified that this treatment works. Not only has research confirmed the efficacy of the medical marijuana, more and more Americans are treating stress-related conditions with the herb. Marijuna for Relaxation According to a study published in 2009 in the Journal of Substance Abuse Treatment, findings suggest that cannabis is commonly used as a stress-coping strategy. Additionally, New Frontier Data, a cannabis data analysis firm, conducted a study last year and revealed: Relaxation (55 percent) is the most widely cited reason why people consume cannabis. The next three most common reasons cited are to relieve stress (40 percent), to enhance the enjoyment of a social experience (40 percent) and to reduce anxiety (39 percent). Women are significantly more likely than men to consume cannabis to relieve stress (+7%) and to reduce anxiety (+13) Relaxation and stress relief are overwhelmingly the most commonly perceived benefits of cannabis use, according to the UK’s Independent Drug Monitoring Unit. And a Yahoo News and Marist College survey found that of the 35 million adults in America using marijuana, 37 percent say they turned to marijuana for relaxation. A History Lesson During the Age of Discovery, physicians and clergymen pioneered the modern use of cannabis as a treatment for stress. In 1621, English clergyman Robert Burton endorsed cannabis for the treatment of depression. And In 1860, the Ohio State Medical Committee on Cannabis concluded: “As a calmative and hypnotic, in all forms of nervous inquietude and cerebral excitement, [cannabis] will be found an invaluable agent, as it produces none of those functional derangements or sequences that render many of the more customary remedies objectionable.” Washington State University at the Forefront As marijuana legalization spreads across the nation – and around the globe – new research demonstrates that these previous cultures were onto something. And scientists from Washington State University are among the leaders in this research. In a first-of-a-kind study earlier this year, Washington State University scientists examined how peoples’ self-reported levels of stress, anxiety and depression were affected by ingesting different quantities and types of cannabis. Their work, published in the Journal of Affective Disorders, reveals that cannabis can significantly reduce short-term levels of depression, anxiety. The study marks one of the first efforts by American scientists to examine how cannabis with varying amounts of tetrahydrocannabinol (THC) and cannabidiol (CBD) affect consumers’ feelings of well-being when consumed outside of a research lab. “Existing research on the effects of cannabis on depression, anxiety and stress are very rare and have almost exclusively been done with orally administered THC pills in a laboratory,” according to Carrie Cuttler, clinical assistant professor of psychology at WSU and lead author of the study. “What is unique about our study is that we looked at actual inhaled cannabis by medical marijuana patients who were using it in the comfort of their own homes as opposed to a laboratory.” Entourage Effect: THC and CBD Work Best Together The WSU researchers discovered that one puff of cannabis high in CBD and low in THC was optimal for reducing symptoms of depression. Two puffs of any type of cannabis reduced symptoms of anxiety. Ten or more puffs of cannabis high in CBD and high in THC produced the largest reductions in stress. “A lot of consumers seem to be under the false assumption that more THC is always better,” Cuttler told Science Daily. “Our study shows that CBD is also a very important ingredient in cannabis and may augment some of the positive effects of THC.” (The synergistic effect of CBD and THC working together is known as the Entourage Effect). Cannabis for Anxiety Reduction The researchers also found that while both genders reported decreases in all three symptoms after using cannabis, women reported a significantly greater reduction in anxiety following cannabis use. Greenlight Approved is a consumer education platform dedicated to “guiding the cannabis curious.” We believe when you start something new, it’s best to start slow. Gather all the information you can to make a safe informed decision. Let Greenlight Approved be your guide so your first experience with cannabis is an educated, safe and positive one. Let us be your resource and guide to participating retailers near you, at www.greenlightapproved.com. http://www.spokesman.com/stories/2018/jul/29/summer-got-you-feeling-stressed-cannabis-may-help/ Bongme
  7. hi Can Legal Cannabis Help Slow the Opioid Drug Epidemic in the U.S.? Imagine stopping 115 needless deaths in the U.S. every day. It's not a guarantee, but with recent developments in cannabis research, experts believe it could be on the horizon. Opioid drug overdoses claim those 115 lives every day in this country. About 60% of opioid addictions are rooted in prescription drug use for a number of ailments, ranging from chronic pain to sports-related injuries to personality disorders. That's where many see cannabis products coming in to help. Read More About Investing In Cannabis Via Real Money "One-hundred fifteen people die every day as a result of opiates nationwide. So from our vantage point, we think cannabis is a sensible solve to a lot of issues," said Acreage Holdings CEO Kevin Murphy. "I believe it's going to be the silver bullet over the next 20 to 30 years as it relates to medical." According to the National Institute on Drug Abuse, 21% to 29% of patients prescribed opioids for chronic pain misuse them. Between 8% and 12% develop an opioid use disorder. Opioid overdoses increased 30% from July 2016 through September 2017. But while the opioid epidemic picked up both momentum and national attention, so too did the spread of regulated medical-use marijuana. Medical cannabis is currently legal in 30 states in the U.S., and has been legal across Canada since 1999. In a 2016 study by Dr. Dustin Sulak, 39% of opioid users who began using cannabis were able to completely stop opioid use and another 39% could reduce their opioid dosage. Sulak found that adding cannabis reduced pain by about 40% in nearly half the treated patients and improved function in 80% of them. "As an effective treatment for chronic pain, it can stop opiod addiction before it occurs," said Dr. Sherry Yafai, medical director of High Sobriety in Los Angeles. Cannabidiol, or CBD, is one of at least 113 cannabinoids found in the cannabis plant. It'a not to be confused with tetrahydrocannabinol, or THC, the cannabinoid in the plant with psychoactive effects. CBD is largely thought to maintain properties of healing and pain relief. But despite the anecdotal evidence from the likes of celebrities and viral social media apostles of the healing qualities of cannabis plants (see Kiss rocker Gene Simmons talk cannabis with TheStreet below), medical experts say there needs to be more research before cannabis can be billed as the solution to the opioid epidemic. For one, the cannabis plant is a complex one. Research professionals haven't yet identified all of the many, many compounds within the plant and how each may contribute to modern medicine. There's reason to believe CBD and THC, taken separately and together, can help with opioid treatment, withdrawal symptoms and pain management. As far as opioid use is concerned, cannabis compounds can enhance pain relief and other medical effects of opioid drugs. Taking cannabis with opioids also widens the therapeutic window, or the time between an effective dose of opioids and a lethal dose, Dr. Sulak said. But perhaps the biggest benefit of cannabis as a part of opioid treatment is that it doesn't carry the risk of overdose. https://www.thestreet.com/lifestyle/can-legal-cannabis-help-slow-the-opioid-drug-epidemic-14613856 Bongme
  8. Hi Published on 9 Jun 2018 TNMNews.com | Marijuana News, Cannabis Culture, Investing Bongme
  9. hi More Women Are Talking To Their Kids About Cannabis, & Experts Say That's Actually Good Almost half of mothers would prefer that their kids dabble with marijuana than alcohol, so more women are talking to their children about cannabis, according to a new study. The women surveyed in the study reportedly feel like they're stigmatized for their use of cannabis, but they're not alone in having conversations with their children about it. These conversations include everything from how to safely consume recreational cannabis to its medical benefits, according to the Georgia Straight, Canada's largest urban weekly. The study was conducted by Van der Pop, a cannabis blog and lifestyle brand. It found that 70 percent of the more than 1,500 North American women polled feel like they're criticized by friends, family, and colleagues for using cannabis, but 89 percent of women said they are talking to their children about cannabis anyway, the Georgia Straight reported. But they're not talking about it telling their kids not to try it — there's less cannabis shaming and warning, and there's a lot more pro-cannabis talk. Using marijuana during adolescence could have a long-term impact on a teen's memory, problem-solving skills, and critical thinking, according to CNN. But while many parents are therefore adviseaczxcd to talk to their kids about what they might lose if they use marijuana during their teenage years, evermore are talking to their kids about how to safely consume it and about its health benefits. Many kids are going to try it at some point anyway, according to Very Well Mind. Among those aged 18 or older who reported lifetime marijuana use, almost 53 percent reported first using marijuana between the ages 12 and 17 — and about two percent reported that they first used marijuana before age 12. Twenty-nine states and the District of Columbia now have laws that legalize marijuana in some form. And the legality of marijuana use seems to have affected how kids perceive cannabis. The American Academy of Pediatrics recently issued new guidelines for doctors and parents to talk to teens about the risks of using marijuana because changes in the legal status of marijuana may lower teen perceptions of the risks, the organization said in a statement. In fact, the National Survey on Drug Use and Health found a decrease in the percentage of 12- to 17-year-olds who said they believe there is a "great risk" in smoking marijuana once a month or one to two times per week. So women might as well be open with their kids about usage. We already know that mothers are more lax about marijuana use these days. More pregnant are smoking pot, according to a study published in the Journal of the American Medical Association. Among pregnant women 18 to 24, 9.8 percent smoked pot in 2009 and 19 percent smoked pot in 2016. While the increase in marijuana use for older age groups was still evident, it wasn't as steep; it rose from 3.4 percent to 5.1 percent among women 25 to 34 years old and from 2.1 percent to 3.3 percent among women older than 34. And 38 percent of parents in the recent Van der Pop also added that they feel like cannabis helps them be more playful and patient as parents. "Cannabis is not the enemy anymore, the way it was when I was growing up," April Pride, founder and CCO of Van der Pop (and mother herself) reportedly told the Georgia Straight. "Parents are closer to their kids and they have a much more transparent relationship surrounding cannabis." The more open parent-child relationships are, the safer children will be; so maybe more moms should be having "the weed talk" with their kids —without scaring them. Vid On Link Bongme
  10. hi Cannabis lounges not limited to Amsterdam anymore. Now, even California has them! On Link To much cut and paste... https://economictimes.indiatimes.com/the-new-amsterdam/slideshow/63313387.cms Bongme
  11. Hi 6 International Cannabis Strains Worth Seeking Abroad Travel is like cannabis; it broadens your perspectives…personally, culturally, and politically,” according to bestselling guidebook author and acclaimed PBS host Rick Steves. “Suddenly, the palette with which we paint the story of our lives has more colors.” For a cannabis enthusiast, this idea of expanding our palettes rings especially true, because even in our current heady era of rapidly advancing legalization, many of the world’s finest and most exotic cannabis strains can only be found in their regions of origin. So if we think of each varietal of the plant as its own unique hue, then we must travel widely to truly experience the species in all its technicolored glory. Much as your local liquor store carries wine and beer from around the world, we should be able to sample the finest cannabis available anywhere without leaving home. Another way to look at this is as an opportunity to get out and do some exploring. As a longtime cannabis journalist, I’ve had the good fortune to travel widely in parts of the world where the love of this plant flourishes, and I can report back that each place comes complete with a particular cannabis strain that’s a point of local pride. Some among the finest I’ve ever sampled. So what are we waiting for? Origin: Barcelona, Spain Much like the coffeeshops in the Netherlands, the cannabis social clubs that have cropped up in Barcelona and elsewhere in Spain over the last decade aren’t really legal, they’re just tolerated—for the most part. Clubs have been busted by the authorities in the past, and the Spanish legal system is still grappling with how to enforce (or not) a set of cannabis laws that allow for “personal” consumption in a “private” setting, without ever defining those terms. The city itself, of course, is one of the world’s ideal places to be stoned. Tapas is the ultimate stoner cuisine, and Gaudi is the best architect ever when you’re high. The most popular local strain when I was there some years ago was Jack Herer, an American-bred varietal that most assuredly flourishes beneath a Spanish sun. But to experience a truly homegrown phenomenon, take the time to track down Cannatonic, a high-CBD strain bred by Spanish seed bank Resin Seeds. With THC rarely above 7% and CBD potentially above 15%, it’s a cross of MK Ultra and G13 Haze with a “slight earthy odor and a mild, sweet, vaguely citrusy flavor.” While not providing much of a high due to its elevated CBD profile, the strain offers profound therapeutic relief for pain, inflammation, and anxiety. It’s the perfect way to unwind after a long hot day wandering La Rambla. Dr. Grinspoon Origin: Amsterdam, Netherlands As a travel destination, Amsterdam offers up many charms, from the picturesque canals and lively nightlife to the parks and museums and a place called Febo, where you can buy deep fried cheese out of a coin-operated automat in the middle of the night. The city’s also been a refuge for cannabis consumers and cannabis itself for decades. Not only have Amsterdam’s famed coffeeshops attracted visitors from around the world since they opened in the 1970s, they’ve also served as a safe haven for cannabis strains from every continent to escape prohibition. If you’re fortunate enough to make a visit, definitely sample some Neville’s Haze or any of its Haze cousins, and don’t miss out on the wide array of imported, traditionally made hashishes available from Morocco, Nepal, Afghanistan, and other distant lands. But if I had to recommend just one smoke in town, I’d say make an appointment with Dr. Grinspoon, a pure sativa heirloom strain bred by Barney’s Farm, a cannabis seed bank associated with one of Amsterdam’s top coffeeshops. Like all purebred sativas, the strain (named for medical cannabis advocate Dr. Lester Grinspoon) takes a long time to harvest and doesn’t yield very well—but who cares? You’re not growing it, you’re smoking it. And the soaring, cerebral, invigorating high will set you off on an adventure to remember (or forget) in one of the world’s most beautiful cities. Lamb’s Bread Origin: Jamaica Jamaica has long been associated with ganja, a local word for cannabis that derives from an ancient Sanskrit word that reached the Caribbean in the mid 1800s, brought along by indentured servants freshly arrived from India. In time ganja spread to native born Jamaicans. In particular, the Indians’ use of cannabis as a spiritual sacrament would be adopted by Jamaica’s Rastafarian community. Add in the global impact of reggae music, and the indelible idea of Jamaica as a cannabis paradise took root in the public’s imagination. Even though, until recently, cannabis remained highly illegal and the laws against it seriously enforced. Happily, however, that all began to change in 2015, when a new law decriminalized up to two ounces of cannabis and made personal grows legal. So how best to celebrate if you happen to be lucky enough to make a pilgrimage? Well, nothing could be more appropriate than rolling up a joint of Lamb’s Bread—the definitive Jamaican cannabis strain, and purportedly Bob Marley’s favorite throughout his life. A bright, green, sticky heirloom sativa, it’s an uplifting, inspiring, energizing high that pairs nicely with a cup of local Blue Mountain coffee if you really want to get your day started right. Origin: Malawi Revered as a food, fiber, and medicine, cannabis flourished throughout Malawi until 1964, when the newly independent republic joined the United Nations and adopted the UN’s Single Convention on Narcotic Drugs. Fifty years of mandated federal enforcement later, what the locals call chumba, and the world calls Malawi Gold, remains a vital cash crop throughout the impoverished African nation, but growers now plant their seeds in remote mountain clearings, hoping to elude the authorities. According to a 2011 report from the World Bank, Malawian farmers harvest around 150,000 pounds of remarkably potent cannabis in this manner every year, the vast majority bound for Europe. The plant remains illicit to this day, but there’s a strong movement in Malawi to legalize both cannabis and hemp. Famous throughout Africa for its potency, Malawi Gold is a pure sativa strain that’s slow to mature, with a flowering time of up to 120 days before it’s ready to harvest. But it’s worth the wait to smoke the long, resin-coated buds that have made the strain famous far beyond Malawi’s borders. Cheese Origin: United Kingdom Britain’s cannabis scene isn’t well known for producing high quality cannabis or award-winning strains, with one notable exception. An indica-dominant hybrid named for its sharply sour aroma, Cheese has been the herbal pride of the United Kingdom since the late 1980s. Local legend has it the original Cheese (sometimes called Original Cheese) descended from a Skunk #1 phenotype that was selected for future breeding based on its incredibly pungent aroma. The most popular modern version comes from Big Buddha Seeds, and features the same pungent funky aroma plus the addition of Afghani indica genetics to increase trichome production and yield. Big Buddha’s version put Cheese on the global map when it took home top honors in the Sativa category at the 2006 Cannabis Cup and has been spreading out geographically ever since. But it’s still best enjoyed at home, in Merry Old England, paired with a cup of Earl Grey and some tasty crumpets. Island Sweet Skunk Origin: Vancouver Island British Colombia—Canada’s westernmost province—stretches from the ocean to the Rocky Mountains. The region became a hotbed for cannabis cultivation starting back in the 1960s, when the ranks of the area’s homegrown farmers were swelled by the arrival of draft resisters from the US who began fleeing to Canada to avoid service in the Vietnam War. With its capital city of Vancouver eventually earning the nickname Vansterdam for its tolerance of cannabis coffeeshops, and the entire province boasting vast stretches of remote land in which to grow cannabis, a culture of tolerance and acceptance took hold in BC even in the darkest days of Canada’s cannabis prohibition. And now that it’s legal nationwide, British Colombia remains the ultimate Canadian cannabis travel destination, a place of natural beauty and vibrant culture. Island Sweet Skunk was originally bred on Vancouver Island, a 290-mile long, largely undeveloped stretch of coastlines and mountains just off the Pacific coast. A sativa with an electric buzz and a flavor profile that mixes classic skunky notes with ripe grapefruit undertones, the strain is a descendant of Skunk #1 and grows tall, straight, high-yielding plants. https://www.leafly.com/news/strains-products/6-international-cannabis-strains-worth-seeking-abroad Bongme
  12. Hi New studies show that legal cannabis access reduces opioid abuse Scientific data is growing nearly by the day in support of the notion that legalized cannabis can mitigate opioid use and abuse. For instance, among states where medical cannabis access is permitted, patients routinely lessen their opioid intake. According to data published this week by the Minnesota Department of Health, among those patients known to be taking opiate painkillers upon their enrollment into the program, 63 percent “were able to reduce or eliminate opioid usage after six months.” Minnesota’s findings are hardly unique. In 2016 there was data gathered from patients enrolled in Michigan’s cannabis access program reported that marijuana treatment “was associated with a 64 percent decrease in opioid use, decreased number and side effects of medications, and an improved quality of life.” A review of state-registered patients from various northeastern states yielded similar results, finding, 77 percent of respondents acknowledged having reduced their use of opioids following cannabis therapy. A significant percentage of respondents also reported decreasing their consumption of anti-anxiety medications (72 percent), migraine-related medications (67 percent), sleep aids (65 percent), and antidepressants (38 percent). A 2017 assessment of medical cannabis patients in Illinois revealed that participants in the state-run program frequently reported using marijuana "as an alternative to other medications -- most commonly opioids, but also anticonvulsants, anti-inflammatories, and over-the-counter analgesics." New Mexico patient data reports: Compared to non-users, medical cannabis enrollees "were more likely either to reduce daily opioid prescription dosages between the beginning and end of the sample period (83.8 percent versus 44.8 percent) or to cease filling opioid prescriptions altogether (40.5 percent versus 3.4 percent)." Two just-published clinical trials from Israel — where medical cannabis use is legally permitted — further affirm this phenomenon. In the first study, which assessed cannabis use among the elderly, investigators reported that over 18 percent of the study's participants "stopped using opioid analgesics or reduced their dose" over a six-month period. They concluded, "Cannabis can decrease the use of other prescription medicines, including opioids." In the second trial, which assessed the safety and efficacy of cannabis in a cohort of over 1,200 cancer patients, scientists reported that nearly half of respondents reported either decreasing or eliminating their use of opioids during the treatment period Another recently published clinical trial provides insight into explaining this relationship. Investigators from Columbia University’s Medical Center assessed the efficacy of low doses of inhaled cannabis and sub-therapeutic doses of oxycodone on experimentally-induced pain in a double-blind, placebo-controlled model. Researchers assessed subjects’ pain tolerance after receiving both substances separately or in concert with one another. While neither the administration of cannabis nor oxycodone alone significantly mitigated subjects’ pain, the combined administration of both drugs did so effectively. Authors determined, “Both active cannabis and a low dose of oxycodone (2.5 mg) were sub-therapeutic, failing to elicit analgesia on their own; however, when administered together, pain responses … were significantly reduced, pointing to the opioid-sparing effects of cannabis.” They concluded, “Smoked cannabis combined with an ineffective analgesic dose of oxycodone produced analgesia comparable to an effective opioid analgesic dose without significantly increasing cannabis abuse liability.” The data is consistent and clear. For many patients, cannabis offers a viable alternative to opioids. It is time for the administration to stop placing political ideology above the health and safety of the American public, and to acknowledge the well-established efficacy of medical marijuana in the treatment of chronic pain. http://thehill.com/opinion/healthcare/376643-new-studies-show-that-legal-cannabis-access-reduces-opioid-abuse Bongme
  13. Hi Women and Men Consume Cannabis In Nearly Equal Numbers: And Other Stats That Will Blow Your Mind As legalization spreads throughout the nation, the cannabis industry is gaining credibility in multiple sectors, including education, testing and consumer data. I recently spoke with Linda Gilbert, Managing Director of Consumer Insights for BDS Analytics, a Colorado-based company specializing in cannabusiness-driven data, who emphasized that, despite the stereotypes, “There is no one cannabis consumer.” There are cannabis users from all walks of life; they just don’t talk about their use in the same way as, say, a twenty-year-old college student does. BDS Analytics has data for days—prepare to have your mind blown by these stats. As someone in the industry, even I was shocked by what Linda was telling me. But hey, numbers don’t lie. The following figures are based on information gathered from adults 21 and over in California, Washington, Oregon and Colorado last year. BDS Analytics groups participants into three categories: Consumers: Someone who has “consumed cannabis within the past six months.” Acceptors: Someone who has “not consumed cannabis within the past six months, but would consider [doing so] in the future.” Rejecters: Someone who has “not consumed cannabis within the past six months and would not consider [doing so] in the future.” Participant category breakdown: Consumers – 28% Acceptors – 34% Rejecters – 38% Yes, Rejecters make up the largest percentage here, but I think it’s more significant to look at the Consumer and Acceptor groups. Together, that means that 62% of participants either partake in cannabis, or would partake in cannabis. That’s huge! And we all know the “lazy stoner” stereotype—that we’re unemployed (or underemployed), unambitious, you name it. But as Linda declared, “People who use cannabis make more money!” See for yourself: Average annual household income Consumers – $72.5.1k Acceptors – $69.1k Rejecters – $69.6k Linda also shocked me with some gender breakdowns. I’ve covered women in cannabis frequently here at DOPE, and have had the pleasure to interview scores of successful women who love weed, but I still figured smoker stats would skew wildly male. Men consume more cannabis than women, yes, but not by as wide of a margin as I anticipated: Gender Breakdown Consumers – 56% male | 44% female Acceptors – 44% male | 56% female Rejecters – 39% male | 61% female The “young stoner” stereotype has also proved false. Linda noted that the average age for smokers in the four states is 42—hardly the twentysomething toker cliché. In their age breakdowns, the highest percentage of Consumers fell in the age 25-34 category with 30%; Acceptors in the 65+ category with 22%; and Rejecters in the 65+ 29%. The Consumer stats aren’t surprising, but it’s remarkable that the age group most interested in trying cannabis happens to be 65+. Other insights include: Millennials are more likely to use cannabis for anxiety and to feel happy (social purposes) while Baby Boomers tend to use cannabis for pain relief. 70% of cannabis users prefer inhalable consumption (bongs, vapes, etc.) but 24% prefer edibles, 4% prefer topicals and 1% prefer “other.” Those who have never used cannabis before or haven’t used cannabis in some time are more likely to consume edibles than any other consumption method. Linda predicts that as more Baby Boomers age and cannabis becomes less stigmatized, edibles will have their heyday, as they’re discrete, precise and provide the option to microdose. Keep an eye out for more innovation in this arena targeted at newbies and older folks, specifically with CBD products. Regardless of age, cannabis is most often used in the evening before bed. 35% of participants report consuming before bed, while 28% consume in the morning (with the rest of participants reporting afternoon usage or multiple sessions throughout the day). People who consume cannabis are more likely to describe themselves as socially conscious; compared to other industries, cannabis consumers are more interested in how things are grown/processed and will pay more for a better, safer product that’s eco-friendly, local—the so-called “cannasseurs.” Mind blown? Me, too. And I write and edit cannabis stories for a living! These stats are proof that, as Linda affirmed, there truly isn’t one single cannabis user. We aren’t lazy, we aren’t mostly men, and we are successful members of society. Put that in your pipe and smoke it! https://www.dopemagazine.com/bds-analytics/ Bongme
  14. Hi Smoking cannabis leads to less tobacco and alcohol consumption on campus Researchers from Oregon conducted a study regarding the effects of legalizing recreational marijuana on the consumption of alcohol and cigarettes on school campuses. In the wake of Oregon’s recent legalization of recreational cannabis, researchers have conducted several studies related to the effects of the legalization on the population. Many cannabis advocates will bring up the fact that cannabis consumption will often lower the consumption of other substances such as alcohol and tobacco. Now we finally know for a fact that this is true, as researchers from Oregon have found a firm relationship between the two. The study is named: “Changes in undergraduates’ marijuana, heavy alcohol and cigarette use following legalization of recreational marijuana use in Oregon”. The study was conducted by Oregon State University researchers David C. R. Kerr, Harold Bae, Sandi Phibbs and Adam C. Kern, who are also the authors of the study. According to their findings: In the combined data trends over time indicated decreasing rates of 30-day cigarette use (from 12.9 to 8.6%) and any heavy alcohol use (from 55.4 to 47.9%). The researchers from the Oregon State University also pointed out that the rates of marijuana use increased from 2015 at six of the seven universities, a trend that was significant overall. In fact, the rate of marijuana use among Oregon’s students also climbed when compared to university and college students from other states. https://greencamp.com/smoking-cannabis-leads-less-cigarettes-alcohol-consumption/ Bongme
  15. Hi How Medical Cannabis Can Be A Silver Bullet For Neuropathy Neuropathy manifests in different ways depending on the sort of nerve damage involved. Neuropathy is a generalized term which signifies exhibited symptoms of nerve damage in human beings—neuropathic pain is one of these symptoms. Neuropathy pain arises from a wide variety of sources that all stem from nerve injury, including: “diabetes mellitus…infections, alcoholism, traumatic injuries, autoimmune diseases, medications, infections, tumors, and inherited disorders”. Due to the aforementioned life afflictions, neuropathy manifests in different ways depending on the sort of nerve damage involved with each specific case. When a patient’s neuropathic symptoms are manifested in the form of physical pain, the resultant condition is often referred to under the umbrella term of “chronic pain”. Taken as a whole, neuropathy and neuropathic pain have no cure—modern day medical research into these disorders exists to better the lives of those patients suffering from these afflictions. For the most part, doctors and patients are looking to medical marijuana as a non-addictive, unobtrusive pain medication that stands in stark contradiction to opioids and other debilitating prescription drugs. n 2014 the World Congress assembled in Buenos Aires, Argentina to discuss the scientific validity of medical marijuana as a pain medicine—neuropathic pain was one of the disorders discussed at the assembly. Mark Ware, who works as “a pain clinician at McGill University, Montreal, Canada” represented the pro-cannabis side of the symposium. Interestingly, Ware argued that medical marijuana is beneficial in neurological pain management as THC and CBD react with the theoretical and somewhat contested endocannabinoid systems in the human body. To illustrate, Ware stated at the assembly: “Throughout the nervous system, endogenous cannabinoids act as synaptic circuit breakers…Because their receptors are widespread, cannabinoids, whether endogenous, plant-derived, or synthetic, regulate neurotransmission in many circuits, including pain producing pathways”. Speculation and scientific jargon aside, there seems to be enough evidence of the beneficial effects of cannabis in relation to neuropathic pain to warrant more research. Various studies have shown that medical marijuana has proven efficacious in lessening pain levels for neuropathic pain patients where other prescription medications have proven un-effective. To illustrate, patients afflicted with diabetes, multiple sclerosis, cancer, central neuropathic pain, and HIV all report that various forms of cannabis use greatly reduce their pain symptoms. More specifically, a similar study reports that smoking marijuana was reported effective for pain management in “12 of 15 chronic pain patients”. In a little known arena of the medical marijuana movement is the fact that FDA approved, synthetic THC compounds have been both legal and prescribed in the United States since 1985—a majority of mainstream medical studies into cannabis have been a result of these drugs. For the most part, these synthesized marijuana compounds have been only prescribed to treat nausea and anorexia for terminally ill cancer and HIV patients. However, many doctors prescribe these meds for chronic / neurological pain as well, even though it is not explicit on prescription labelling and paperwork. Moreover, the Canadian medical field has developed and prescribed a pain medication derived from synthesized THC and CBD that they labeled “nabiximols”. In a somewhat ironic twist, many medical professionals feel that synthesized cannabis products are safer, for both the short and long term use, than traditional plant-based organic cannabis flowers. The irony in this concept is evident as the U.S. government has only allowed for medical testing in relation to synthesized THC and CBD compounds, while criminalizing the use of a simple plant. https://thefreshtoast.com/cannabis/how-medical-cannabis-can-be-a-silver-bullet-for-neuropathy/ Bongme
  16. Hi A startup that makes cannabis oil for vaping wants to be America's first $1 billion 'marijuana unicorn' Cura Cannabis Solutions, a startup that makes marijuana oil for vape cartridges, wants to be the first US company in the cannabis industry to achieve elusive "unicorn" status with a billion dollar valuation. "We've had a lot of nicknames. 'Unicorn' is definitely a new one," said Cura president and cofounder Cameron Forni. Cura is currently raising funding at a $400 million valuation, which represents a 1,300% increase from its valuation in 2016 and puts it ahead of the combined market value of the two biggest publicly traded marijuana companies in the US: Terra Tech and Kush Bottles. The Oregon-based company closed the year with $40.5 million in sales, and it predicts revenue will rise to $120 million in 2018 as California's recreational marijuana market comes online. Sales of recreational marijuana began in California on January 1, and the state market is expected to haul $3.7 billion in revenue this year as dispensaries pop up in new cities and counties. Cura, which operated in California's medical marijuana market, is positioned to piggyback on the market's success because it already has distribution there. The vaping market is also exploding. In California, vaporizers account for 32% of sales on Eaze, a marijuana delivery service. In 2017, 72% of millennial Eaze customers bought a vaporizer. Cura's colossal growth stems from a decision it made early on to focus exclusively on cannabis oil, a product that's highly concentrated in the chemical compounds found on the outside of the plant. The company does not grow its own marijuana, but sources it from third-party farmers. The company's signature line of vape cartridges, Select Oil, uses a Japanese organic cotton wick that absorbs the oil through its fibers and delivers it to a heating chamber. According to Forni, the system allows users to take quick draws without the burned taste of a standard cotton wick. Select Oil offers over a dozen formulations with various potencies, flavors, and desired effects. Its biggest seller is a $60 cartridge called Select Elite, which has the highest concentration of THC, the psychoactive ingredient in marijuana, of all its vape cartridges. Cura has been able to scale quickly by having a broad supply chain. In 2017, there were 240 licensed marijuana farms in Oregon, and 180 of them sold all of their trim (plant material that's leftover from trimming the marijuana bud) to Cura for making oil, according to the company. Some cannabis brands say that being vertically integrated — growing the plant that's processed for oil or other products — allows for greater quality control. Brands also pocket a bigger profit, because they don't have to share the revenue with farmers and middlemen distributors. "What other industry does everything from production to processing to retail?" said Forni, who got into the cannabis industry after working on agriculture technology. "In cannabis, these companies want to be the best at everything. It's very difficult to be the best at everything." Cura sells its products in California, Nevada, Oregon, and is eyeing an expansion to Arizona, Florida, New Jersey, and Ohio. It also provides oil wholesale to marijuana edibles makers. Cura has been hiring like crazy to keep up with new market demand, growing from 200 to 285 employees since December. Forni spends much of his time commuting between headquarters in Portland and Cura's outposts in California and Nevada. It's like "being strapped to a rocketship and trying to keep your eyes open," Forni said. Cura's CEO, Nitin Khanna, has remained at the helm of the company in spite of allegations leveled against him. In 2014, Khanna settled a civil suit accusing him of sexual battery and rape. http://uk.businessinsider.com/cura-cannabis-solutions-marijuana-oil-company-2018-1 Bongme
  17. hi My last post until Monday have a great weekend and stay safe The scientist leading the largest marijuana study in history says it's '5x stronger' than in 1980 — but there's a catch An increasing number of Americans live in states where recreational marijuana is legal. CU Boulder psychiatry professor Christian Hopfer is helping lead one of the largest and most long-term studies of marijuana in history. He says marijuana has gotten up to 5 times stronger since the 1980s, but tracking THC potency over time can be tricky. One in five Americans lives in a state where it's legal to use marijuana without a doctor's prescription. Yet we know surprisingly little about the drug's effects on our health. Rumors abound, while the science is sparse. One of the most common rumors is that marijuana today is stronger than it was in the 1970s and 80s. The truth: yes and no. Dispensaries in some states are routinely selling flower that is "at least five times as strong" as it was 40 years ago, Christian Hopfer, a professor of psychiatry at the University of Colorado at Boulder's Anschutz Medical Campus and one of the lead researchers on a forthcoming $5.5-million study of cannabis, told Business Insider. Hopfer's study will be the largest and most long-term analysis of cannabis to date. Hopfer's research has taken him to dispensaries around the state of Colorado, where he said he's seen a variety of marijuana sold with a content breakdown of around 25% THC, the active ingredient in marijuana that's responsible for the high. "It used to be 2-5%, so this stuff is potent," Hopfer said. That's not just true in Colorado. The THC content of marijuana across the US has tripled since 1995, according to a large recent study. For the study, researchers at the University of Mississippi reviewed close to 39,000 samples of cannabis that had been seized across the country by the Drug Enforcement Administration. While THC levels hovered around 4%, on average, in 1995, they skyrocketed to roughly 12% in 2014. Meanwhile, the CBD content in marijuana — the part that's responsible for many of the drug's therapeutic effects — has dropped, the researchers found, shifting the ratio of THC to CBD from 14:1 in 1995 to about 80:1 in 2014. Still, tracking THC potency over time can be tricky. The older a weed sample gets, the more its THC appears to degrade. How it is stored matters too. These are two barriers that could be interfering somewhat with the metrics on pot's potency. A 2012 review of 17 studies analyzing marijuana potency, for example, noted that most of the studies they reviewed did "not describe relevant information about the features (i.e. conservation status and age of the sample) of the analyzed ... cannabis samples." Nevertheless, most researchers agree that weed appears to be getting progressively stronger, although they differ in opinion about precisely how much. There's another issue at play here. While researchers might be able to conclude that weed is getting stronger, they can't necessarily say whether or not people are increasing their dose — or by how much. A 2014 study published in the journal Addiction, for example, found that regular weed users naturally adjust their consumption somewhat based on potency, inhaling less smoke when the marijuana is higher in THC. Despite taking smaller inhales, however, those users still took in a higher THC dose. The researchers were not able to draw any definitive conclusions about the potential ties between higher doses and addiction. A more important predictor of addiction, they concluded, was people's individual smoking behavior (i.e. how many puffs they took, how much smoke they inhaled, and how long their puffs lasted). In this setting, a new approach to addressing cannabis — and its dosage — is desperately needed, Hopfer said. "I think we’ve dealt with marijuana historically from a criminal justice perspective, but if you switch to an environment where it's legal, you switch to a public health perspective. And to do that right, we need more scientific research." http://uk.businessinsider.com/marijuana-has-gotten-stronger-more-potent-research-science-2017-10 Vid On Link Bongme
  18. Hi Female Cannabis Users Smarter Than Those Who Don’t? Could it be that cannabis actually makes women smarter? This brand new study has some interesting findings A new study is suggesting that women who use cannabis regularly have higher IQs than those who don’t… The Journal of Epidemiology and Community Health took a close look at 800 female participants, focusing on intelligence, grades, smoking habits etc. The Journal found that as well as the regular cannabis users having a higher IQ than the general public, women with a 50 percent higher IQ were likely to use cannabis regularly. The study leaders were shocked to find the results, and were left scrambling for a “why.” There are some good guesses, but to date, no on is totally sure. The main crux of it surrounds women who use cannabis being more open to new experiences. That being the case, many suggest that using cannabis regularly may raise IQ as a result of this openness. Often, it is thought, women who use cannabis regularly are more inspired, have more get up and go, and are more driven to experience new things. Coupled with the fact that cannabis is healthy, depending on how it is consumed, it bodes well for intelligent people who prefer natural remedies to dangerous meds prescribed by doctors. While the study presents many great questions it stops short of offering many solid answers. Yes the participants were smarter in terms of IQ if they use cannabis but really the question is why? Is it really to do with this new experience theory or is there more to it? Could it be related to a change of brain chemistry or something even more medical than that? While we may not have all the answers right now, studies like these are a step in the right direction when it comes to understanding the numerous health benefits of cannabis, whether medically, or it seems, recreationally. http://www.cannatech.news/2017/10/04/female-cannabis-users-smarter-dont/ Bongme
  19. Hi Those Stoned Climbers Have More to Teach Us About Cannabis Consumption Than You Might Think vogue magazine Cannabis is slowly becoming a mainstream product as state laws continue to change and brands launch innovative lifestyle offerings around the psychotropic plant. (Think: Laced lip balms, snaked-skin joint holders, and vegan dark chocolate caramels sprinkled with matcha salt.) But on Saturday, when four hikers summited Scafell Pike in England, the country’s tallest mountain, and got too high to climb down, all the old stoner stereotypes came streaming across the Twittersphere. The group had to be rescued after consuming too much cannabis and becoming “incapacitated,” Cumbria police said in a statement. The British authorities deployed mountain rescue to bring the hikers back safely down to earth. The incident sparked public outrage. This news, while perhaps a small setback for an industry looking to distance itself from the drug’s less illustrious connotations and position itself at the forefront of the booming wellness movement with cannabis-infused recipe books and yoga retreats, is not the only time in recent years that consumption of a marijuana product has earned notoriety in the media. In 2009, Michael Phelps was suspended from swimming for three months after a British tabloid ran a full page picture of the Olympian smoking pot out of a bong. He was 23. Leading ultra-marathoner Jenn Shelton sparked ethical debate when she told the Wall Street Journal that she uses cannabis in her training. And the renowned New York Times columnist Maureen Dowd made waves when she wrote about her experience with edibles: after consuming about eight times the recommended dosage while in Colorado, she said, she thought she was dying. (According to the National Institute on Drug Abuse, you cannot die from consuming too much marijuana—cannabis is not lethal on its own—but users can experience panic attacks, paranoia, impaired judgement and motor skills and other unpleasant effects.) So, cannabis: A wellness product or an intoxicating drug? According to a growing number of experts, it can be either, depending on who you are and your mental history (cannabis is not recommended for people with serious mental conditions, including schizophrenia), and how cannabis affects your mind and body. What you're consuming (a few puffs from a vape pen or a bite of a low-dose edible will affect you differently than pulls from a joint or bong), where you are and how much you consume also matters greatly. And thanks to its entrance into the realm of legally controlled substances, with about 29 states and Washington, D.C. having some kind of state-regulated medical marijuana program, and eight states with recreational marijuana laws, there is an increasing body of evidence that, paired with a few simple rules, can help make the gray area less hazy. Dr. Perry Solomon, MD, a board-certified anesthesiologist who is also the Chief Medical Officer of HelloMD, one of the industry's largest online communities that connects patients who suffer from chronic pain and a range of other illnesses with doctors who can offer tailored medical marijuana recommendations, agrees. “For some people, cannabis can help them attain a psychological space that blocks out extraneous things and focus on their mind, body and one repetitive motion,” answers Solomon when asked whether or not cannabis and wellness can go hand-in-hand. Such potential benefits may make it well-suited to mind-body practices like meditation; and a new wave of exercise retreats, yoga studios, and sporting events and gyms (see The 420 Games and Power Plant Fitness) are exploring its role in mild forms of exercise. However you plan to incorporate it into an active lifestyle, experts stress that the key to reaping its self-care benefits may lie in treating the drug with the same respect for dosage and potency as one might any other controlled substance, from alcohol to pharmaceuticals. “No one recommends climbing 3,000 feet and getting stoned,” says Dr. Solomon. “You also need to realize that cannabis can affect you differently depending on what you’re doing, what you ate, and yes, what altitude you’re used to. You can use the same [marijuana] product one day and feel a different affect another day.” For those living where it's legal, here are a few expert-approved ground rules on how to find wellness in cannabis. Start Low, Go Slow The mantra is pasted on billboards and signs across states like Colorado for a reason. While those dipping into the drug for the first time should consult a medical professional, since there are no official guidelines as to what constitutes a proper dose universally, people without a tolerance to THC should generally stick between 2 mg and 2.5 mg for their first couple of times until they're used to the effects, according to Solomon. Satori, which makes medical-grade cannabis-infused edibles out of coffee beans, blueberries and California raisins, touts a micro-dosing friendly bite ranging from 1 milligram per piece up to 10mg. Know Your Dose Dosing matters. Hmbdlt, a vape pen company with the tagline "delivering health and happiness" in Santa Barbara, makes hospital-white, precise low-dose pens that vibrate after a modest 2.25mg of THC oil is dispensed. The system is offered via a range of six formulas, including Sleep, which is developed out of a sleep-promoting terpene blend that helps calm the body and mind, and Arouse, which claims to elevate moods thanks to its ultra-relaxing THC blend of linalool and farnesene terpenes, delivered along with a floral and green apple-like aroma. "Different people require different doses of medicine and it's the same with cannabis," says Gunner Winston, the company's CEO. "That's our focus: dosing technology.” Try CBD-Only Alternatives Instead If you aren’t ready to feel the plant’s psychotropic effects, topicals (lotions, balms, and oils) and treats infused with CBD—the non-psychoactive cannabinoid with medicinal qualities such as anti-inflammation—are a way to tread lightly into the lifestyle because neither will get you high. Cindy Capobianco, co-founder of Lord Jones, the luxe cannabis-infused as well as hemp-derived CBD-infused line of edibles and topicals out of California that has been collaborating on wellness events with Equinox, says she and her husband Rob took their time before putting their low-dose, CBD-rich gum drops and cooling body lotions on shelves. “We developed and designed our products for people who were cannabis curious, but also fearful of having a bad experience,” says Capobianco. Other brands offering high-end topicals in an effort to ease-in the inexperienced include Marley Natural, which also has a line of branded marijuana, Apothecanna, one of the industry's first all-natural beauty lines derived by cannabis and therapeutic-grade essential oils, and Kiva, a cannabis-infused chocolatier that recently launched its own line of CBD-only confections. Their tagline? "A higher chocolate experience." https://www.vogue.com/article/stoned-climbers-best-cannabis-lifestyle-brands-dose-vape-pens-wellness-california-scafell-pike-england Bongme
  20. hi No, God Did Not Prescribe the Use of Cannabis in the Bible Christian Today News Just when you think you've heard it all, a pastor calls your radio show asking how to respond to a congregant who claims that cannabis was sanctioned by God in the Torah. That's right, sanctioned by the Lord Himself, not to be smoked but to be burned in large quantities by the priests of Israel. Far out! To be sure, there was a time in my life when I would have readily believed something like this, since I spent 1969-1971 as a heavy drug-using, hippie rock drummer, consuming everything from pot to LSD and from speed to heroin. Not surprisingly, when my two best friends starting reading the Bible, telling me about the more esoteric passages in the Scriptures – all kinds of visions and dreams and revelations – I asked them in jest, "What were they smoking?" That, in fact, is what I asked the pastor (again, in jest) who called the show: What is this congregant smoking? It turns out that there is an alleged scholarly basis for this bogus belief, namely, that the Hebrew words qaneh-bosem in Exod 30:23 refer to marijuana, or, more specifically, hemp. And note the apparent similarity in the words: qaneh-bosem and cannabis. That proves it, right? According to the Herb Museum website, it was in 1936 that a little-known Polish professor named Sara Benetowa (later Sula Benet) wrote, "The sacred character or Hemp in biblical times is evident from Exodus 30:22- 23, where Moses was instructed by God to anoint the meeting tent and all its furnishings with specially prepared oil, containing hemp." This was allegedly confirmed by other Hebrew scholars. And obviously, with the rising popularity of marijuana in today's culture, arguments like this have great appeal for Christians who want to get high. Not only did their state pass a pro-pot law, but God's into it too! As one website proclaims in bold, red letters: "The fact is that the Holy Oil contained 6 Pounds of (Marijuana) with other spices boiled into one gallon of Olive oil! The Holy Oil of God is illegal to obtain today!!!" Really! During my drug-using years, I often went to rock concerts at the Fillmore East in New York, seeing groups like Led Zeppelin and the Who and the Grateful Dead and Jethro Tull, among many others. It was the perfect concert atmosphere, seating only about 2,000 people and with a dynamic light show behind the performers. But it was also a hippie paradise, since the whole place smelled like pot. Is that what the ancient Temple smelled like in Jerusalem? Maybe the priests got high on mushrooms too! Returning to reality, the alleged connection between qaneh-bosem and cannabis simply doesn't exist. Note first that qaneh-bosem is two words in Hebrew, not one. And the words are easily translated, qaneh meaning a stalk or reed, and bosem meaning "sweet smelling." Some scholars translate the words together to refer to "aromatic cane," "scented cane," or "sweet-smelling cane," others "sweet calamus" or "fragrant calamus." But not a single scholarly, biblical Hebrew lexicon in the world connects these words with cannabis. I can say that emphatically because I own them all, in multiple languages. The alleged connection isn't there. It is also certain, for various phonetic and linguistic reasons, that the word cannabis, which comes from the Greek kannabis, is not related to these two Hebrew words. To put it bluntly, there's no more connection between Hebrew qaneh-bosem and Greek kannabis than there is between "Moses" and "mice." As for those who can't study the issue for themselves, note carefully this commandment to Aaron, the High Priest, and his successors: "Drink no wine or strong drink, you or your sons with you, when you go into the tent of meeting, lest you die. It shall be a statute forever throughout your generations" (Lev. 10:9). Sobriety was a must for those coming into the presence of God. This makes the claim all the more ridiculous that the Lord commanded large amounts of pot to be burning in this very same holy place. Yes, be sure not to drink any wine or strong drink, but go ahead and inhale deeply! As for those Christians who feel that smoking pot "in moderation" is fine, since it's now legal in their state, a word of caution. First, pot remains a gateway drug, often leading to the use of other, harder drugs, along with becoming addictive in and of itself. Second, pot today is far more potent than when I smoked it more than 46 years ago. Third, new studies are pointing to health risks and driving risks associated with marijuana. (See here on pot use in Colorado.) Fourth, you'll have a hard time fulfilling the biblical mandate to "be sober and vigilant" (1 Peter 5:8) while smoking a joint. In any case, people will have to sort out the question of smoking pot, just as they sort out the question of drinking. (The subject of medical marijuana is another question entirely.) What I can tell you without hesitation is that God never prescribed pot – as incense or to be smoked – anywhere in the Bible. That's a fact. https://www.christiantoday.com/article/no.god.did.not.prescribe.the.use.of.cannabis.in.the.bible/114431.htm Bongme
  21. hi Cannabis Is Becoming Increasingly Popular Among Senior Citizens Cannabis use among those over 65 increased by 300% between 2002 and 2014. The number of senior citizens who are using cannabis is on the rise according to national and state data, signaling the need for more research on how cannabis affects the aged. Cannabis use among those over 65 has increased by 300% between 2002 and 2014, according to the Centers for Disease Control. Demographic data from Colorado confirms that the percentage of seniors who are registering for medical marijuana cards has also been steadily increasing since 2014, and as of last month, 21% of all medical marijuana users in the state are over 61. University of Iowa professor Brian Kaskie, along with Dr. Sara Qualls at the University of Colorado at Colorado Springs, recently won a $97,500 grant to study how older adults use cannabis. The researchers are conducting focus groups throughout Colorado to collect information on older cannabis users. Kaskie said that there is a relatively large amount of data on cannabis use among minors and young adults, but little relating to older adults. “Older adults are for example more likely to have a prescription medication to begin with. And so how does the use of cannabis intersect with that?” he said. “That becomes one question — we don’t know.” Kaskie hopes that the research will help create an accurate portrait of an older cannabis user. “We have to think about other outcomes that are relevant to them, like does this help you reduce your dependency on opioids? Or does this lead to you feeling more anxious? Or a whole host of other outcomes that are specific to older adults.” While Kaskie and Qualls are trying to learn more about cannabis and seniors, Dr. Joe Cohen is trying to educate seniors about cannabis. Cohen has recently been holding “Cannabis 101 for Seniors” talks at retirement communities in Colorado. The doctor said that many of the seniors he has spoken to are still concerned about the stigma of cannabis use, and are afraid of or unwilling to experience any of the psychoactive effects of cannabis as a result. Cohen informs his patients that they can benefit from the healing properties of cannabis without getting high. “We see a lot of arthritic conditions whether it be osteoarthritis, or degenerative disc disease, back problems, we see a lot of what we call neurodegenerative diseases, which are more common in the elderly population — that can be anything from Parkinson’s to multiple sclerosis,” Cohen said. The doctor recommends CBD for many of these patients, as it has a variety of medical benefits, but is not psychoactive. https://merryjane.com/news/cannabis-is-becoming-increasingly-popular-among-senior-citizens Bongme
  22. Hi Cannabis Industry Becoming one of the Fastest Growing Sectors With Infusion of Innovative Services and Technology Advancements The cannabis industry is estimated in the billions of dollars annually with the market continuing to expand at an impressive rate as well as dispensaries popping up all throughout the country and North America. The latest innovation in technology and industry targeted services supporting the cannabis markets are allowing consumers to find their CBD and legal marijuana products of interest or even locating the nearest dispensary which in the end result is boosting the already impressive cannabis economy as a whole. Active companies in the market today include: Leafbuyer Technologies Inc. (OTC: LBUY), Kush Bottles Inc. (OTC: KSHB), 22nd Century Group Inc. (NYSE: XXII), Medical Marijuana Inc. (OTC: MJNA), and Aurora Cannabis Inc. (OTC: ACBFF) (TSX: ACB.TO). Leafbuyer Technologies, Inc. (OTC: LBUY), a leading cannabis technology platform, announced today an expanded partnership with Voice Media Group , one of the nation's largest diversified media organizations. This expanded partnership broadens the advertising relationship first established between Leafbuyer and Voice Media Group in Q4 of 2016. Together, the two companies installed a customized application on the marijuana section of Westword.com, helping visitors discover Leafbuyer deals on their favorite cannabis-related products. "Our clients immediately praised the influx of new business, and we are building off that success as we expand into other legal markets," said Leafbuyer's VP of Business Development, Mark Breen. Read this and more news for Leafbuyer Technologies at: http://www.marketnewsupdates.com/news/lbuy.html . Given the rapid legalization of marijuana across the nation and Leafbuyer's transition into a public company (OTC: LBUY), expanding the partnership nationwide was a natural fit. Kurt Rossner, CEO of Leafbuyer stated, "We believe the added distribution footprint will greatly enhance our ability to attract new customers in areas outside of Colorado. This is a very important step as we continue to push forward for a truly national base of consumers." Special offers from Leafbuyer's dispensary and product clients will appear in marijuana and music related pages of the following Voice Media Group websites: Westword, LA Weekly, Phoenix New Times, and Toke of the Town . In all, the online tool will reach over one million page views per month. "We had partnered with Leafbuyer for our Westword Magazine in Denver six months ago. It was an easy decision to include them in all markets on our Marijuana related sections. The Cannabis industry is one of the fastest growing industries to date and our partnership with Leafbuyer has provided valuable content for our users," said Scott Tobias, CEO of Voice Media Group. In other industry news and developments from around the sector: Kush Bottles Inc. (OTCQB: KSHB) came to a close up 3.98% on Tuesday at $2.09 with over 270,000 shares traded on the day. The company recently announced it has launched an FDA compliant Kush Canister™ to safely and securely store cannabis products for resale purposes. The canister can fit just over one ounce of cannabis flower and has a certified child resistant push-top to comply with regulations in the states that require child resistant packaging. The proprietary product is manufactured in the U.S.A. and is designed specifically for markets that require child resistant packaging. The material used to manufacture this container is food grade and BPA free. 22nd Century Group Inc. (NYSE: XXII) closed up 5.10% on Tuesday at $2.68 with over 2.4 million shares traded by the market close. 22nd Century's wholly-owned subsidiary, Botanical Genetics, LLC, with a worldwide license agreement with Anandia Laboratories Inc. holds an exclusive sublicense in the United States and a co-exclusive sublicense in the remainder of the world, excluding Canada, to patents and patent applications relating to the cannabis plant that are required for the production of cannabinoids, the major active ingredients in the cannabis plant. The Anandia sublicense continues through the life of the last to expire patent, which is expected to be 2035. The Company's ongoing research is product-oriented and focused on developing a range of next generation industrial hemp plants that contain optimized levels of medically important cannabinoids, such as CBD, CBC, and CBG. In collaboration with the Company's university research partners, Botanical Genetics is also working to optimize Hemp varieties for various climates around the world. THC-free cannabis is an ideal agricultural crop and an excellent source of medically important cannabinoids. 22nd Century has the exclusive rights to commercialize the plants arising from these collaborative projects in the United States. Medical Marijuana Inc. (OTC: MJNA) closed up 2.90% on Tuesday with over 8.8 million shares traded by the market close. The company recently announced that August 2017 was the Company's largest revenue month in its history. Additionally, wholly-owned subsidiaries Kannaway® and HempMeds® Mexico experienced their largest months of revenue in their respective histories. "Kannaway's growth has been particularly stunning since it's re-launch in March 2016," said Kannaway CEO, Blake Schroeder. "Kannaway's revenue has increased over 25 times during that time-period, and the company intends to launch a series of new products in Q4 2017 as it gears up for its regional convention this fall in Denver, Co. Additionally, there are plans to launch into Europe later this year. We fully expect Kannaway's aggressive growth to continue!" Aurora Cannabis Inc. (OTCQX: ACBFF) (TSX: ACB.TO) on Tuesday closed up 1.35% at $2.25 on the OTC Markets trading over 1 million shares traded and closed up slightly on the Toronto Exchange at $2.73 on over 2.3 Million shares traded by the market close. The company recently announced it has surpassed 19,000 active and pending registered patients less than 20 months after the Company's first product sale in January, 2016. Aurora added approximately 3,000 patients during the months of July and August, 2017. Aurora is on track to set a new monthly revenue record, projecting gross revenues for cannabis sales in Canada and Germany to exceed $3.0 million for August 2017 . In Canada , the Company anticipates selling more than 275,000 grams or gram equivalents of cannabis products, and shipping approximately 15,000 orders this month. Both figures represent new highs for Aurora. Exceptional demand for the Company's cannabis oil products has proven to be a significant revenue driver, with sales now representing approximately 26% of gross revenues. DISCLAIMER: MarketNewsUpdates.com (MNU) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. MNU is NOT affiliated in any manner with any company mentioned herein. MNU and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. MNU's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. MNU is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed MNU has been compensated twenty three hundred dollars for news coverage of the current press release issued by Leafbuyer Technologies Inc. by the company. MNU HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE. This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and MNU undertakes no obligation to update such statements. http://www.prnewswire.co.uk/news-releases/cannabis-industry-becoming-one-of-the-fastest-growing-sectors-with-infusion-of-innovative-services-and-644177743.html Bongme
  23. hi Does marijuana affect your sleep? (The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Deirdre Conroy, University of Michigan (THE CONVERSATION) If you speak to someone who has suffered from insomnia at all as an adult, chances are good that person has either tried using marijuana, or cannabis, for sleep or has thought about it. This is reflected in the many variations of cannabinoid or cannabis-based medicines available to improve sleep – like Nabilone, Dronabinol and Marinol. It’s also a common reason why many cannabis users seek medical marijuana cards. I am a sleep psychologist who has treated hundreds of patients with insomnia, and it seems to me the success of cannabis as a sleep aid is highly individual. What makes cannabis effective for one person’s sleep and not another’s? While there are still many questions to be answered, existing research suggests that the effects of cannabis on sleep may depend on many factors, including individual differences, cannabis concentrations and frequency of use. Access to cannabis is increasing. As of last November, 28 U.S. states and the District of Columbia had legalized cannabis for medicinal purposes. Research on the effects of cannabis on sleep in humans has largely been compiled of somewhat inconsistent studies conducted in the 1970s. Researchers seeking to learn how cannabis affects the sleeping brain have studied volunteers in the sleep laboratory and measured sleep stages and sleep continuity. Some studies showed that users’ ability to fall and stay asleep improved. A small number of subjects also had a slight increase in slow wave sleep, the deepest stage of sleep. However, once nightly cannabis use stops, sleep clearly worsens across the withdrawal period. Over the past decade, research has focused more on the use of cannabis for medical purposes. Individuals with insomnia tend to use medical cannabis for sleep at a high rate. Up to 65 percent of former cannabis users identified poor sleep as a reason for relapsing. Use for sleep is particularly common in individuals with PTSD and pain. This research suggests that, while motivation to use cannabis for sleep is high, and might initially be beneficial to sleep, these improvements might wane with chronic use over time. We were interested in how sleep quality differs between daily cannabis users, occasional users who smoked at least once in the last month and people who don’t smoke at all. We asked 98 mostly young and healthy male volunteers to answer surveys, keep daily sleep diaries and wear accelerometers for one week. Accelerometers, or actigraphs, measure activity patterns across multiple days. Throughout the study, subjects used cannabis as they typically would. Our results show that the frequency of use seems to be an important factor as it relates to the effects on sleep. Thirty-nine percent of daily users complained of clinically significant insomnia. Meanwhile, only 10 percent of occasional users had insomnia complaints. There were no differences in sleep complaints between nonusers and nondaily users. Interestingly, when controlling for the presence of anxiety and depression, the differences disappeared. This suggests that cannabis’s effect on sleep may differ depending on whether you have depression or anxiety. In order words, if you have depression, cannabis may help you sleep – but if you don’t, cannabis may hurt. Cannabis is still a schedule I substance, meaning that the government does not consider cannabis to be medically therapeutic due to lack of research to support its benefits. This creates a barrier to research, as only one university in the country, University of Mississippi, is permitted by the National Institute of Drug Abuse to grow marijuana for research. New areas for exploration in the field of cannabis research might examine how various cannabis subspecies influence sleep and how this may differ between individuals. One research group has been exploring cannabis types or cannabinoid concentrations that are preferable depending on one’s sleep disturbance. For example, one strain might relieve insomnia, while another can affect nightmares. Other studies suggest that medical cannabis users with insomnia tend to prefer higher concentrations of cannabidiol, a nonintoxicating ingredient in cannabis. This raises an important question. Should the medical community communicate these findings to patients with insomnia who inquire about medical cannabis? Some health professionals may not feel comfortable due to the fluctuating legal status, a lack of confidence in the state of the science or their personal opinions. At this point, cannabis’s effect on sleep seems highly variable, depending on the person, the timing of use, the cannabis type and concentration, mode of ingestion and other factors. Perhaps the future will yield more fruitful discoveries. http://www.michigansthumb.com/news/article/Does-marijuana-affect-your-sleep-12187298.php Bongme
  24. hi Global Cannabis Testing Market: Which Would Be The Major Factors Responsible For Global Market Growth? The global cannabis testing market is expected to grow with the CAGR of approximately XX% during the forecast period 2017-2022. Cannabis is a flowering plant, primarily found is Asia, Africa and the America. It is non-conventionally utilized in hemp oils, hemp fiber that is used for medicinal purpose. The market growth is primarily driven due to some crucial factors such as rising demand for LIMS system in cannabis testing and legalization on the utilization of cannabis on medicine as it is effective for the treatment of various diseases such as cancer anorexia/cachexia and neurologic disorders etc. Cannabis testing was legalized in 25 states in the United States. Cannabis Testing Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). The report introduced the Cannabis Testing basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world’s main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis. On the basis of geography, North America held major share, in terms of revenue in 2015. The factors such as the legalization of cannabis for medical use which leads to rise in cannabis testing companies in the United States, high growth in the cannabis testing laboratories and the presence of major players in the region. Furthermore, increasing awareness regarding medical cannabis and increasing funding for the cannabis industry are the key factors boosting market growth in this region. However, Asia Pacific is also expected to witness potential growth in the market due to increasing awareness regarding drug testing in the region. https://www.medgadget.com/2017/09/global-cannabis-testing-market-which-would-be-the-major-factors-responsible-for-global-market-growth.html Download sample pages of this report: Bongme
  25. hi Can Cannabis Help With Health Issues During Pregnancy? Cannabis use has been debated in the public opinion for over a century now. Despite the fact that the ups and downs marijuana has gone through, today such states as Alaska, Oregon, Colorado, and Washington among others have decided to legalize the herb’s use for recreational purposes while more than 25 others are legalizing it for medical use. According to research findings by Pew Research Center, there has been a rapid shift in the attitude in public opinion about cannabis. That is why there is immense support for marijuana legalization in many of the states. According to their research conducted in 2015, a majority of Americans, actually 53% support legalization of pot as compared to 44% who oppose its legalization. Despite the opposition cannabis has gone through for many years, it is now touted that the drug can help with some ailments and health issues. Believe it or not, today many pregnant women are turning to marijuana to cure some health issues during pregnancy. This is according to a Metro report. Some of the health issues many pregnant women are concerned about include; Morning sickness Many women have been reported arguing that marijuana is a better option compared to prescription medication in treating morning sickness. While some pregnant women continue using this drug for fun, some are forced into it simply because of the terrible pain and morning sickness. Many consider this as an alternative to the common painkillers that have otherwise proven unsafe during pregnancy. With limited options to deal with the nauseating pain for the entire pregnancy period, most of the women turn to marijuana to get rid of the debilitating morning sickness. According to a research study carried out in 2014 and published in the Hawaii Journal of Medicine and Public Health, Marijuana is very effective in pain management hence the reason many pregnant women turn to it to suppress the morning sickness and pain. According to the research, some respondents indicated a reduction in pain and anxiety after using the drug. Depression and anxiety A number of pregnant women are reported to experience mood swings and chronic stress among other symptoms of depression. According to scientists at the University of Buffalo’s Research Institute on Addictions, the brain has the similar chemical makeup to that of cannabis, endocannabinoids. According to the scientists, chronic stress may lead to reduced production of this chemical makeup by the brain leading to depression-like behavior. For this reason, the scientists argue that the components of marijuana may thus be useful in reducing cases of depression and chronic stress in pregnant women and all other people in general by restoring the normal levels and function. The chemical compound produced in the brain similar to that found in cannabis affects motor control, emotions, behaviors, and cognition. From this point of view, the researchers indicate a crucial health benefit of cannabis. Lack of appetite, nausea, and vomiting These are common health conditions that affect pregnant women. Though the medical use of cannabis remains controversial in many states, in the US, FDA has approved medications containing synthetic THC such as dronabinol and nabilone which are prescribed as appetite stimulants for people without appetite such as the pregnant women. The medications are also used in the treatment of several other conditions like chemotherapy related nausea and vomiting. Pregnancy-associated risks of marijuana While there seem to be quite many medical benefits of cannabis, should it be assumed that this drug is all safe and good for pregnant women? This is a question many people tend to ask. According to Dr. Schmidt, there is a big difference between recreational and medical marijuana. In that sense, any pregnant woman intending to use this drug should first get the doctor’s approval. According to the doctor, it is critical that pregnant women seek other conventional medications for morning sickness and other pregnancy related health issues before trying out marijuana. American Medical Association has many times suggested that all Marijuana products to be labeled with warnings of possible harm. However, this is yet to be concluded as more research is being carried out to determine whether prenatal cannabis use is responsible for the various health consequences alleged out there such as low birth weight, premature birth, stillbirth, small head circumference and small length among others. A team of researchers leads by Dr. Shayna Conner performed a systematic review of observational studies comparing the rate of cannabis use and birth outcomes. According to their research findings, there was no statistical correlation between marijuana use and the negative birth outcomes mentioned above. According to the American Congress of Obstetricians and Gynecologists, it is not recommended to take cannabis during pregnancy. They, however, note that it is still not certain what the specific side effects of marijuana are on pregnancy and the unborn child. Other studies indicate that unborn children exposed to cannabis indicated signs of late neurological development, attention deficit, poor motor control and weak problem-solving skills as compared to those that are not exposed. On the other hand, a conflicting study indicates no link between prenatal exposure to marijuana and school performance. This is a clear indication of conflicting research results on whether marijuana is healthy or not. Most of the research studies carried out on Marijuana have been performed on animals, and for the fact that there isn’t a clear match between human and animal studies, it cannot be concluded from the research results that the findings are authentic. Conclusion So far, it is clear that there are many conflicting research findings concerning the use of marijuana during pregnancy. However, it is also clear that not a single research finding has pointed out the harmful effects of marijuana, not even the FDA which has fought so hard to have this herb illegalized. While you might have the urge to use it for various health issues during pregnancy, it is ideal to try some other conventional medication or to seek the advice of your doctor before going ahead to use this controversial herb. References https://www.health.harvard.edu/blog/the-health-effects-of-marijuana-from-recreational-and-medical-use-2016081910180 https://www.acog.org/Resources-And-Publications/Committee-Opinions/Committee-on-Obstetric-Practice/Marijuana-Use-During-Pregnancy-and-Lactation http://safebirthproject.com/marijuana-and-pregnancy-facts/ -----0 http://www.huffingtonpost.com/entry/can-cannabis-help-with-health-issues-during-pregnancy_us_599d2ae0e4b02289f7619128 Bongme